MARK YACKLEY: Open Payments
NPI 1356347215 · HUTCHINSON, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$957 in 68 payments from 20 companies in 2025. Trend: 2023 $1,402 · 2024 $1,356 · 2025 $957
Food & beverage: $957
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $250 |
| Amgen Inc. | 17 | $169 |
| ABIOMED | 4 | $97 |
| Lilly USA, LLC | 4 | $66 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $64 |
| Phathom Pharmaceuticals, Inc. | 4 | $42 |
| Sumitomo Pharma America, Inc. | 2 | $31 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $29 |
| SANOFI PASTEUR INC. | 1 | $26 |
| Daiichi Sankyo Inc. | 1 | $25 |
Products named: Ozempic, EVENITY, Rybelsus, Kerendia, OTEZLA, MOUNJARO, VOQUEZNA, GEMTESA.
Industry payments across KS — which companies pay providers there.
